Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Regulatory News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

30 Sep 2020 14:27

RNS Number : 6378A
Motif Bio PLC
30 September 2020
 

 

 

Motif Bio plc

 

("Motif Bio" or the "Company")

 

Result of AGM

 

Motif Bio plc (AIM: MTFB) announces that at the Annual General Meeting of the Company held earlier today at the offices of ONE Advisory Limited, 201 Temple Chambers, 3-7 Temple Avenue, London, EC4Y 0DT all but one of the resolutions put to members were passed on a poll.

 

The Board notes that resolution 7, which was proposed as a special resolution regarding the disapplication of pre-emption rights, was not passed.

 

The number of votes lodged by proxy and voted on by poll for and against each of the resolutions proposed, and the number of votes withheld, were as follows:

 

Resolution

FOR*

%

AGAINST

%

WITHHELD

Resolution 1 (Ordinary)

To receive the Company's annual accounts and the strategic, directors' and auditors' reports for the year ended 31 December 2019.

 

37,371,686

 

91.94

 

 

3,275,355

 

8.06

 

 

131,590

Resolution 2 (Ordinary)

To re-elect Graham Lumsden as a Director of the Company

 

27, 167,596

 

66.74

 

 

13,541,866

 

33.26

 

 

69,169

Resolution 3 (Ordinary)

To re-elect Christopher Wardhaugh as a director of the Company, who was appointed by the board since the last annual general meeting.

 

 

34,740,854

 

 

85.42

 

 

 

5,930,684

 

 

14.58

 

 

 

107,093

Resolution 4 (Ordinary)

To re-appoint the Company's auditor Crowe LLP, who have been appointed by the board since the last annual general meeting.

 

 

37,286,396

 

 

91.56

 

 

 

 

3,437,066

 

 

8.44

 

 

 

55,169

Resolution 5 (Ordinary)

That the Directors be authorised to fix the auditors remuneration.

 

36,844,682

 

 

90.71

 

 

 

3,772,431

 

9.29

 

 

161,518

Resolution 6 (Ordinary)

To empower the directors to allot relevant securities pursuant to Section 551 of the Act

 

33,534,192

 

84.95

 

 

5,941,430

 

 

15.05

 

 

1,303,009

Resolution 7 (Special)

To disapply the pre-emptive rights contained in Section 561 of the Act

 

26,246,162

 

73.09

 

 

 

9,844,855

 

26.91

 

 

4,187,614

 

 

 

*including votes granting discretion to the chair

 

As at 30 September 2020, there were 654,991,023 ordinary shares in issue. Shareholders are entitled to one vote per share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.

 

 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

For further information please contact:

 

Motif Bio plc

 

ir@motifbio.com

Jonathan Gold (President and Chief Business Officer)

 

 

 

 

SP Angel Corporate Finance LLP (NOMAD & BROKER)

 

+44 (0) 20 3470 0470

David Hignell/Caroline Rowe (Corporate Finance)

 

Vadim Alexandre/Abigail Wayne (Sales & Broking)

 

 

 

Walbrook PR Ltd. (UK FINANCIAL PR & IR)

+44 (0) 20 7933 8780

Paul McManus/ Lianne Cawthorne

motifbio@walbrookpr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBXGDCXDXDGGG
Date   Source Headline
15th Jun 20217:00 amRNSCancellation - Motif Bio plc
14th Jun 202112:24 pmRNSResult of General Meeting
11th Jun 20212:59 pmRNSGeneral Meeting – Dial in Details
2nd Jun 20219:32 amRNSUpdate on Share Consolidation & Admission Warrants
26th May 20214:00 pmRNSSchedule One - Motif Bio plc
26th May 20213:00 pmRNSUpdate on Proposed Reverse Takeover
10th May 20217:00 amRNS2020 Annual Report and Accounts
29th Mar 20217:00 amRNSUpdate re proposed Reverse Takeover
26th Feb 20217:00 amRNSUpdate re Motif BioSciences Inc
27th Jan 20217:00 amRNSUpdate re proposed Reverse Takeover
5th Jan 20217:00 amRNSBusiness Update
12th Oct 20207:00 amRNSHalf-year Report
30th Sep 20202:27 pmRNSResult of AGM
23rd Sep 20207:00 amRNSNotification of Interim Results
9th Sep 20207:00 amRNSAnnual Report and Accounts & Notice of AGM
1st Sep 20207:00 amRNSFinal Results
29th Jul 20207:30 amRNSSuspension - Motif Bio Plc
29th Jul 20207:30 amRNSSuspension of Trading on AIM
28th Jul 20204:41 pmRNSSecond Price Monitoring Extn
28th Jul 20204:36 pmRNSPrice Monitoring Extension
22nd Jun 20207:00 amRNSDelay in publication of Final Results
17th Jun 20204:41 pmRNSSecond Price Monitoring Extn
17th Jun 20204:36 pmRNSPrice Monitoring Extension
12th Jun 202012:41 pmRNSHolding(s) in Company
5th Jun 20201:55 pmRNSHolding(s) in Company
4th Jun 20201:32 pmRNSHolding(s) in Company
2nd Jun 20204:42 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
1st Jun 20207:00 amRNSBusiness update & Appointment of Strategic Adviser
29th May 20207:00 amRNSTotal Voting Rights
21st May 202012:20 pmRNSHolding(s) in Company
19th May 202010:30 amRNSHolding(s) in Company
15th May 20207:00 amRNSExercise of Warrants
12th May 20205:02 pmRNSHolding(s) in Company
5th May 20207:00 amRNSPlacing to raise £650,000
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSDirectorate Changes & Corporate Update
15th Apr 20204:41 pmRNSSecond Price Monitoring Extn
15th Apr 20204:36 pmRNSPrice Monitoring Extension
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:37 pmRNSPrice Monitoring Extension
14th Apr 20201:21 pmRNSStmnt re Share Price Movement
9th Apr 20204:40 pmRNSSecond Price Monitoring Extn
9th Apr 20204:36 pmRNSPrice Monitoring Extension
9th Apr 202012:08 pmRNSSecond Price Monitoring Extn
9th Apr 202012:03 pmRNSPrice Monitoring Extension
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20205:30 pmRNSMotif Bio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.